Jt Stratford LLC Bristol Myers Squibb CO Transaction History

Jt Stratford LLC

$568 Million
Q3 2024

A detailed history of Jt Stratford LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Jt Stratford LLC holds 10,625 shares of BMY stock, worth $616,250. This represents 0.1% of its overall portfolio holdings.

Number of Shares

10,625

Previous 10,861 2.17%

Holding current value

$616,250

Previous $451,000 21.73%

% of portfolio

0.1%

Previous 0.09%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$39.66 - $51.75 $9,359 - $12,213	-236 Reduced 2.17%	10,625 $549,000
Q2 2024 Aug 14, 2024	BUY	$40.25 - $52.99 $437,155 - $575,524	10,861 New	10,861 $451,000
Q2 2023 Aug 14, 2023	BUY	$63.71 - $70.74 $4,077 - $4,527	64 Added 1.31%	4,932 $315,000
Q1 2023 May 10, 2023	BUY	$65.71 - $74.53 $77,143 - $87,498	1,174 Added 31.78%	4,868 $337,000
Q4 2022 Feb 14, 2023	BUY	$68.48 - $81.09 $5,341 - $6,325	78 Added 2.16%	3,694 $265,000
Q3 2022 Nov 14, 2022	BUY	$0.13 - $76.84 $33 - $19,901	259 Added 7.72%	3,616 $257,000
Q2 2022 Aug 15, 2022	BUY	$72.62 - $79.98 $726 - $799	10 Added 0.3%	3,357 $258,000
Q1 2022 May 12, 2022	SELL	$61.48 - $73.72 $3,627 - $4,349	-59 Reduced 1.73%	3,347 $244,000
Q4 2021 Feb 11, 2022	SELL	$53.63 - $62.52 $3,217 - $3,751	-60 Reduced 1.73%	3,406 $212,000
Q3 2021 Nov 15, 2021	BUY	$59.17 - $69.31 $4,378 - $5,128	74 Added 2.18%	3,466 $205,000
Q2 2021 Aug 16, 2021	SELL	$61.91 - $67.42 $52,623 - $57,307	-850 Reduced 20.04%	3,392 $227,000
Q1 2021 May 12, 2021	SELL	$59.34 - $66.74 $991,630 - $1.12 Million	-16,711 Reduced 79.75%	4,242 $268,000
Q4 2020 Feb 16, 2021	BUY	$57.74 - $65.43 $36,145 - $40,959	626 Added 3.08%	20,953 $1.3 Million
Q3 2020 Nov 13, 2020	SELL	$57.43 - $63.64 $16,195 - $17,946	-282 Reduced 1.37%	20,327 $1.23 Million
Q2 2020 Aug 14, 2020	BUY	$54.82 - $64.09 $23,901 - $27,943	436 Added 2.16%	20,609 $1.21 Million
Q1 2020 May 14, 2020	SELL	$46.4 - $67.43 $273,713 - $397,769	-5,899 Reduced 22.63%	20,173 $1.12 Million
Q4 2019 Feb 14, 2020	SELL	$49.21 - $64.19 $694,205 - $905,528	-14,107 Reduced 35.11%	26,072 $1.67 Million
Q3 2019 Nov 19, 2019	SELL	$42.77 - $50.71 $165,733 - $196,501	-3,875 Reduced 8.8%	40,179 $2.04 Million
Q2 2019 Aug 14, 2019	BUY	$44.62 - $49.34 $79,066 - $87,430	1,772 Added 4.19%	44,054 $2 Million
Q1 2019 May 15, 2019	SELL	$45.12 - $53.8 $182,781 - $217,943	-4,051 Reduced 8.74%	42,282 $2.02 Million
Q4 2018 Feb 14, 2019	SELL	$48.76 - $63.23 $173,195 - $224,592	-3,552 Reduced 7.12%	46,333 $2.41 Million
Q3 2018 Nov 14, 2018	BUY	$55.19 - $62.25 $3,476 - $3,921	63 Added 0.13%	49,885 $3.1 Million
Q2 2018 Aug 13, 2018	BUY	$50.53 - $62.98 $91,610 - $114,182	1,813 Added 3.78%	49,822 $2.76 Million
Q1 2018 May 14, 2018	SELL	$59.92 - $68.98 $4,134 - $4,759	-69 Reduced 0.14%	48,009 $3.04 Million
Q4 2017 Feb 15, 2018	BUY	$59.94 - $65.35 $24,275 - $26,466	405 Added 0.85%	48,078 $2.95 Million
Q3 2017 Nov 14, 2017	BUY	$55.23 - $63.74 $2.63 Million - $3.04 Million	47,673	47,673 $3.04 Million

Others Institutions Holding BMY

# of Institutions

2,536

Shares Held

1.47B

Call Options Held

31.6M

Put Options Held

35M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $123B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jt Stratford LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jt Stratford LLC with notifications on news.

Account